Table 3 Comparison of baseline demographics and clinical parameters of patients in Early Azathioprine (EAZ) versus Late Azathioprine (LAZ) groups
Demographics | EAZ (n = 16) | LAZ (n = 17) | p value |
|---|---|---|---|
N (%) or mean ± SD or median (range) | |||
Gender | |||
Males | 12 (54.5%) | 10 (45.5%) | 0.32 |
Females | 4 (36.4%) | 7 (63.6%) | 0.38 |
Race | |||
Chinese | 7 (50%) | 7 (50%) | |
Malay | 1 (16.7%) | 5 (83.3%) | |
Indian | 6 (60%) | 4 (40%) | |
Others | 2 (66.7%) | 1 (33.3%) | |
Median Age at presentation in years and (range) | 11.5 (3–16) | 14 (4–17) | 0.18 |
Clinical parameters | |||
BMI z-score | −1.12 ± 0.9 | −1.5 ± 1.9 | 0.43 |
PCDAI baseline | 32.1 ± 8.3 | 33.1 ± 10.3 | 0.77 |
Hemoglobin g/dL | 11.3 ± 1.2 | 11.4 ± 1.7 | 0.80 |
Albumin g/L | 30.6 ± 6.1 | 30.7 ± 8.6 | 0.97 |
Platelets × 109 | 471 ± 175 | 456 ± 150 | 0.79 |
ESR mm/h | 63.2 ± 37.5 | 41.3 ± 16.9 | 0.03 |
CRP mg/L | 42.1 ± 40.3 | 47.1 ± 61.3 | 0.79 |